Cargando…

SPLUNC1 α6 Peptidomimetic: A Novel Therapeutic for Asthma

Detalles Bibliográficos
Autor principal:	Vlahos, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8937236/ https://www.ncbi.nlm.nih.gov/pubmed/34905718 http://dx.doi.org/10.1165/rcmb.2021-0451ED

Ejemplares similares

Investigation of Anti-Infection Mechanism of Lactoferricin and Splunc-1
por: Tsou, Yung An, et al.
Publicado: (2014)

Tobacco exposure inhibits SPLUNC1-dependent antimicrobial activity
por: Moore, Patrick J., et al.
Publicado: (2019)

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”
por: Cai, Jianfeng, et al.
Publicado: (2021)

α1-antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice
por: Jiang, Di, et al.
Publicado: (2013)

CC16 drives VLA-2-dependent SPLUNC1 expression
por: Iannuzo, Natalie, et al.
Publicado: (2023)

SPLUNC1 is a negative regulator of the Orai1 Ca(2+) channel
por: Wu, Tongde, et al.
Publicado: (2022)

Increased susceptibility to otitis media in a Splunc1-deficient mouse model
por: Bartlett, Jennifer A., et al.
Publicado: (2015)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection
por: Jiang, Shasha, et al.
Publicado: (2019)

Identification of BPIFA1/SPLUNC1 as an epithelium-derived smooth muscle relaxing factor
por: Wu, Tongde, et al.
Publicado: (2017)

A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal Disease
por: Mashbat, Bayarchimeg, et al.
Publicado: (2020)

Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic Fibrosis
por: Bingle, Lynne, et al.
Publicado: (2007)

The Multifunctional Host Defense Peptide SPLUNC1 Is Critical for Homeostasis of the Mammalian Upper Airway
por: McGillivary, Glen, et al.
Publicado: (2010)

Correction to: A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal Disease
Publicado: (2022)

Erratum: An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection
por: Akram, K M, et al.
Publicado: (2018)

SPLUNC1 regulation in airway epithelial cells: role of toll-like receptor 2 signaling
por: Chu, Hong Wei, et al.
Publicado: (2010)

Human Neutrophil Elastase Degrades SPLUNC1 and Impairs Airway Epithelial Defense against Bacteria
por: Jiang, Di, et al.
Publicado: (2013)

FSTL-1: A New Player in the Prevention of Emphysema
por: Vlahos, Ross
Publicado: (2020)

Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice
por: Musa, Maslinda, et al.
Publicado: (2012)

Enhanced biofilm prevention activity of a SPLUNC1-derived antimicrobial peptide against Staphylococcus aureus
por: Yu, Zhongjie, et al.
Publicado: (2018)

The SPLUNC1-βENaC complex prevents Burkholderia cenocepacia invasion in normal airway epithelia
por: Ahmad, Saira, et al.
Publicado: (2020)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Antimicrobial Peptidomimetics: Reinterpreting Nature to Deliver Innovative Therapeutics
por: Scorciapino, Mariano A., et al.
Publicado: (2012)

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease
por: Recio, Carlota, et al.
Publicado: (2017)

Lung SPLUNC1 Peptide Derivatives in the Lipid Membrane Headgroup Kill Gram-Negative Planktonic and Biofilm Bacteria
por: Jakkampudi, Tanvi, et al.
Publicado: (2023)

Novel Nitrile Peptidomimetics for Treating COVID-19
por: Chia, C. S. Brian
Publicado: (2022)

Editorial to the Special Issue “Pathogenesis and Novel Therapeutics in Asthma”
por: Bazan-Socha, Stanisława, et al.
Publicado: (2023)

Gammaherpesvirus infection modulates the temporal and spatial expression of SCGB1A1 (CCSP) and BPIFA1 (SPLUNC1) in the respiratory tract
por: Leeming, Gail H, et al.
Publicado: (2015)

Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment
por: Liu, Xinyu, et al.
Publicado: (2022)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Lipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy?
por: Vlahos, Ross
Publicado: (2020)

Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging
por: Jaiswal, Anil Kumar, et al.
Publicado: (2022)

Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics
por: Paul, Ashim, et al.
Publicado: (2017)

α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia
por: Kennedy, Adam C., et al.
Publicado: (2020)

Oxetanyl Peptides: Novel Peptidomimetic Modules for Medicinal Chemistry
por: McLaughlin, Martin, et al.
Publicado: (2014)

Investigating the Interaction of Cyclic RGD Peptidomimetics with α(V)β(6) Integrin by Biochemical and Molecular Docking Studies
por: Civera, Monica, et al.
Publicado: (2017)

SPLUNC1 Regulates Cell Progression and Apoptosis through the miR-141-PTEN/p27 Pathway, but Is Hindered by LMP1
por: Chen, Pan, et al.
Publicado: (2013)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2aljtpd15eb3ohm87vvm81uv5m